Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Clinical trial NCT01591577 · COMPLETED
Trial details
- NCT number
- NCT01591577
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-07
- Primary completion
- 2024-05-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.